{
    "nct_id": "NCT06721507",
    "official_title": "Preoperative Tirzepatide for Bariatric Surgery",
    "inclusion_criteria": "* adults who have been enrolled in the multidisciplinary metabolic and bariatric surgery program at the UK HealthCare Weight Loss Surgery Clinic and are scheduled to receive laparoscopic or robotic sleeve gastrectomy\n* BMI greater than or equal to 45 kg/m2 with one or more obesity-related comorbidities\n* have demonstrated abstinence from any form of nicotine use, confirmed by serum nicotine and metabolite testing\n* have expressed preference and are deemed a suitable candidate for laparoscopic or robotic vertical sleeve gastrectomy\n* enrollment in the ADORE Bariatric Tissue Bank (IRB #69767)\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* any contraindication to the use of tirzepatide (per package insert)\n* Personal or family history of medullary thyroid carcinoma\n* Patients with Multiple Endocrine Neoplasm syndrome type 2\n* Hypersensitivity to tirzepatide\n* History of pancreatitis\n* Type 1 Diabetes\n* patients with active, untreated or symptomatic cholelithiasis or jaundice\n* current use of a GLP-1 or GLP-1/GIP receptor agonist, or use within past 90 days\n* a history of prior metabolic and bariatric surgery\n* diagnosed autoimmune disease\n* current use of immunosuppressive agents or use within the past 30 days\n* moderate or severe substance use disorder according to DSM-5 criteria\n* uncontrolled significant psychiatric disorder as assessed by specialized bariatric psychologist\n* female participant who is pregnant, breast-feeding, or intends to become pregnant with in 1 year following surgery\n* a prisoner",
    "miscellaneous_criteria": ""
}